An electronic micropump to deliver treatments deep within the brain.
16.04.2015 - Press release
it is essential to act at exactly the right time and place in the brain. For this reason, the team of researchers led by Christophe Bernard at Inserm Unit 1106, “Institute of Systems Neuroscience” (INS) have developed an organic electronic micropump which, when ...
Production of human motor neurons from stem cells is gaining speed
10.11.2014 - Press release
Researchers at the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem - Inserm/AFM/UEVE) have recently developed a new approach to produce different populations of motor neurons from these cells in only 14 days. ...
Working toward improved management of cranial trauma
18.07.2014 - Press release
Under normal conditions and because it cannot store oxygen, the brain cannot withstand being deprived of oxygen for more than a few minutes without risking serious consequences. After an accident (cranial trauma or stroke), emergency teams therefore try to restore cerebral oxygenation ...
Laser bioprinting in Bordeaux : an innovative approach
04.07.2014 - Press release
One of the goals of the laboratory is to develop laser and microfabrication technologies with the aim of printing tissues in vitro and in vivo. The researchers in the laboratory were pioneers in Europe, developing laser-assisted bioprinting from 2005. This Inserm/University of ...
Innovative strategy to facilitate organ repair
17.04.2014 - Press release
A team led by Ludwik Leibler from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI Paris Tech) and Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universités Paris Diderot and Paris 13), has just demonstrated that the principle of adhesion by aqueous solutions ...
Parkinson’s disease: an immense step forward thanks to gene therapy
10.01.2014 - Press release
A French and English team (AP-HP, Inserm, UPEC, CEA/Mircen, Oxford Biomedica, Cambridge University) has conducted a clinical phase 1/2 gene therapy study among patients suffering from an evolved form of Parkinson’s disease. Fifteen patients were able to benefit from this new treatment, ...